Progress and Challenges of Novel Immunotherapy Targets 2025.07.01 Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer 2025.07.01 New Practices in Precision Tumor Immunotherapy 2025.07.01 HER2-targeted Efficacy Prediction Model Based on Gastric Cancer Microenvironment Characteristics 2025.07.01 Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer 2025.07.01 Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer 2025.07.01 Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer 2025.07.01 Early research, clinical practice and thinking of innovative NK cell therapy 2025.07.01 «previous next»
